Comment
doi: 10.1016/s0140-6736(98)22937-0.
Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study
Affiliations
- PMID: 9742972
- DOI: 10.1016/s0140-6736(98)22937-0
Item in Clipboard
Comment
Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study
Lancet.
.
No abstract available
Comment on
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet. 1998 Sep 12;352(9131):837-53. Lancet. 1998. PMID: 9742976 Clinical Trial.
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet. 1998 Sep 12;352(9131):854-65. Lancet. 1998. PMID: 9742977 Clinical Trial.
Similar articles
-
UKPDS and beyond: into the next millennium. United Kingdom Prospective Diabetes Study.Diabetes Obes Metab. 1999 Jan;1(1):13-22. doi: 10.1046/j.1463-1326.1999.00009.x. Diabetes Obes Metab. 1999. PMID: 11221807 Review. No abstract available.
-
Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).Diabetologia. 2001 Mar;44(3):298-304. doi: 10.1007/s001250051617. Diabetologia. 2001. PMID: 11317659 Clinical Trial.
-
Follow-up of intensive glucose control in type 2 diabetes.N Engl J Med. 2009 Jan 22;360(4):416; author reply 418. doi: 10.1056/NEJMc082275. N Engl J Med. 2009. PMID: 19164195 No abstract available.
-
10-year follow-up of intensive glucose control in type 2 diabetes.N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10. N Engl J Med. 2008. PMID: 18784090 Clinical Trial.
-
[++UKPDS Study. Metformin in obese patients with Type 2 diabetes (UKPDS 340].Internist (Berl). 2000 Jul;41(7):688-9. doi: 10.1007/s001080050590. Internist (Berl). 2000. PMID: 10929259 Review. German. No abstract available.
Cited by
-
Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.J Clin Hypertens (Greenwich). 2005 Feb;7(2):73-80. doi: 10.1111/j.1524-6175.2005.03869.x. J Clin Hypertens (Greenwich). 2005. PMID: 15722651 Free PMC article.
-
Transforming growth factor beta contributes to progressive diabetic nephropathy.Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7667-9. doi: 10.1073/pnas.97.14.7667. Proc Natl Acad Sci U S A. 2000. PMID: 10884396 Free PMC article. No abstract available.
-
Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.BMC Endocr Disord. 2016 Jul 8;16(1):39. doi: 10.1186/s12902-016-0120-z. BMC Endocr Disord. 2016. PMID: 27391319 Free PMC article.
-
A survey of diabetes care in general practice in England and Wales.Br J Gen Pract. 2000 Jul;50(456):542-5. Br J Gen Pract. 2000. PMID: 10954934 Free PMC article.
-
Acute Administration of Metformin Protects Against Neuronal Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury via Regulation of the AMPK/CREB/BDNF Pathway.Front Pharmacol. 2022 Apr 1;13:832611. doi: 10.3389/fphar.2022.832611. eCollection 2022. Front Pharmacol. 2022. PMID: 35431946 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
